Efficacy of adalimumab in the treatment of generalized granuloma annulare in monozygotic twins carrying the 8.1 ancestral haplotype.
Knoell
Keith Allen
KA
D034861:Abdominal Wall; D000068879:Adalimumab; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001706:Biopsy; D005260:Female; D005500:Follow-Up Studies; D016460:Granuloma Annulare / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics; D006680:HLA Antigens / Q000235:genetics*; D006239:Haplotypes; D006801:Humans; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D014430:Twins, Monozygotic / Q000235:genetics*
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D006680:HLA Antigens; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab